From: p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Target protein | Antibody | Type | Provider |
---|---|---|---|
Bax | p-19a | polyclonal | Santa Cruz |
Bcl-2 | 100/D5 | polyclonal | Novocastra/YLEM |
Cathepsin D | cat-D | polyclonal | DAKO |
Cyclin D1 | DCS6 | monoclonal | Novocastra/YLEM |
Cyclin E | 13A3 | monoclonal | Novocastra/YLEM |
ERα | MU368-UC | monoclonal | Biogenex |
Her-2/erb-B/neu | Hercep-test | polyclonal | DAKO |
Ki-67 | MIB-1 | monoclonal | Novocastra/YLEM |
p16/INK4 | p16 | polyclonal | Pharmingen |
p27/kip1 | F-8 | monoclonal | Santa Cruz |
p53 | DO7 | monoclonal | NeoMarkers |
PAI-1 | sc-6642 | polyclonal | Santa Cruz |
PgR | 1A6 | polyclonal | Ventana |
Stromelysin/MMP11 | sc-8837 | polyclonal | Santa Cruz |
uPA | sc-6830 | polyclonal | Santa Cruz |